Skip to content

Eli Lilly’s Weight-Loss Drug Demand Is Nearly Limitless. Here’s What Comes Next For The $1 Trillion Drugmaker

Eli Lilly (NYSE:LLY) opened Wednesday’s session with a blowout second-quarter earnings report, sending shares sharply higher and cementing the drugmaker’s status as the only pharmaceutical company trading above a $1 trillion market cap. The biggest question today for Lilly is… This post appeared first on… Read More »Eli Lilly’s Weight-Loss Drug Demand Is Nearly Limitless. Here’s What Comes Next For The $1 Trillion Drugmaker

Musk Refuses To Confirm It, But This SpaceX Rumor Should Terrify Every Tesla Investor

On Wednesday’s earnings call, Elon Musk stopped short of confirming a Tesla-SpaceX merger and did something arguably worse for shareholders of Tesla (NASDAQ:TSLA): he refused to shut the door. Nothing was confirmed. Nothing was denied. Here is the part that should worry Tesla holders… This… Read More »Musk Refuses To Confirm It, But This SpaceX Rumor Should Terrify Every Tesla Investor

Just A Handful Of AI Stocks Are Carrying Everything. History Says It Doesn’t Have To End Badly

For much of the past three years, artificial intelligence has been the market’s defining investment theme. Companies building AI chips, cloud infrastructure, memory, and software have driven earnings growth while many other stocks have struggled to keep pace. That leadership is becoming even more concentrated.… Read More »Just A Handful Of AI Stocks Are Carrying Everything. History Says It Doesn’t Have To End Badly